Search

Search Constraints

You searched for: Author/Creator Blando, Jorge

Search Results

1. Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018)

2. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. (December 2018)

3. High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer. Issue 1 (16th December 2019)

4. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (November 2018)

5. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study. Issue 4 (April 2017)

6. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Issue 9 (October 2017)

7. Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. (December 2018)

8. The distribution of T‐cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Issue 9 (30th November 2018)

9. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Issue 4 (22nd November 2019)